2416258-53-0
Chemical Structure
Cap-dependent endonuclease-IN-5
- CAS No.: 2416258-53-0
- Formula:C27H21F2N3O4S2
- Molecular Weight:553.60
IUPAC Name: (R)-12-((S)-9,10-difluoro-2-methyl-6,11-dihydrobenzo[e]thieno[3',2':5,6]benzo[1,2-b]thiepin-6-yl)-7-hydroxy-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
InChIKey: ZBSGCGAWEFAVSO-IRLDBZIGSA-N
SMILES: O=C1N2[C@](COCC2)([H])N([C@@H]3C4=CC=C5C=C(C)SC5=C4SCC6=C(F)C(F)=CC=C36)N7C1=C(O)C(C=C7)=O
Biological Activity: Cap-dependent endonuclease-IN-5 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-5 inhibits influenza virus well, and/or has lower cytotoxicity, better in vivo pharmacokinetic properties and in vivo pharmacodynamic properties (extracted from patent WO2020078401A1, compound 13-1)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cap-dependent endonuclease-IN-5 | Cap-dependent endonuclease-IN-5 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-5 inhibits influenza virus well, and/or has lower cytotoxicity, better in vivo pharmacokinetic properties and in vivo pharmacodynamic properties (extracted from patent WO2020078401A1, compound 13-1). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
